European Ambulance Acute Coronary Syndrome (ACS) Angiography Trial

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2198 participants.

Also called NCT01087723

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 2,198 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01087723
Other papers using this trial's data
  • Bivalirudin started during emergency transport for primary PCI The New England journal of medicine, 2013-12-05 DOI, PubMed 24171490
  • Frequency and prognostic significance of access site and non-access site bleeding and impact of choice of antithrombin therapy in patients undergoing primary percutaneous coronary intervention. The EUROMAX trial International journal of cardiology, 2016-05-15 DOI, PubMed 26995053
  • Impact of arterial access site on outcomes after primary percutaneous coronary intervention: prespecified subgroup analysis from the EUROMAX trial Circulation. Cardiovascular interventions, 2015-06 DOI, PubMed 26056249
  • One-Year Mortality for Bivalirudin vs Heparins Plus Optional Glycoprotein IIb/IIIa Inhibitor Treatment Started in the Ambulance for ST-Segment Elevation Myocardial Infarction: A Secondary Analysis of the EUROMAX Randomized Clinical Trial JAMA cardiology, 2017-07-01 DOI, PubMed 28273285, PMC5543319 Not in the PMC Open Access subset.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Austria, Czechia, Denmark, France, Germany, Italy, Netherlands, Poland, Slovenia (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01087723. Randomized; no masking; primary purpose treatment. Start 2010-03 (registry gives no type); primary completion 2013-08 (actual). Results posted on 2016-02-12.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
European Ambulance Acute Coronary Syndrome (ACS) Angiography Trial
Acronym
EUROMAX
Condition
Acute Coronary Syndrome
Intervention (Drug)
Bivalirudin
Intervention (Drug)
Heparin
Lead sponsor
The Medicines Company (class: industry)

Record details

Record id
cardio:ct-nct01087723
Content hash
c7d3222d4ecb5b057bbaf58501ea784220960e6422ca5c0b56b3028be1f0f731